Hemorrhoidectomy: Surgical Removal of Hemorrhoids — Cost, Top Hospitals & Success Rates | MyMedicPlus

Hemorrhoidectomy is the surgical excision of hemorrhoidal tissue — enlarged, swollen vascular cushions in the anal canal and lower rectum. It is the most effective long-term treatment for advanced hemorrhoidal disease and carries the lowest recurrence rate of any available intervention.

Hemorrhoids are graded on a four-point scale. Grade I lesions bleed but do not prolapse; Grade II prolapse during straining and reduce spontaneously; Grade III require manual reduction; and Grade IV remain permanently prolapsed and cannot be reduced. Hemorrhoidectomy is most commonly indicated for Grade III and Grade IV internal hemorrhoids, and for large symptomatic external hemorrhoids or mixed hemorrhoidal complexes that have not responded to non-surgical measures such as dietary fibre supplementation, sitz baths, rubber-band ligation, or sclerotherapy.

The global prevalence of symptomatic hemorrhoidal disease is estimated at 4–5% of the general population, rising steeply with age. Chronic straining, pregnancy, low-fibre diet, prolonged sitting, portal hypertension, and family history are recognised risk factors. While most cases are managed conservatively or with office-based procedures, approximately 10% of symptomatic patients ultimately require surgery.

Modern hemorrhoidectomy techniques — open (Milligan-Morgan), closed (Ferguson), stapled hemorrhoidopexy (PPH), and transanal hemorrhoidal dearterialization (THD) — differ in wound closure, tissue handling, and post-operative pain profile, but all achieve comparable cure rates. Choosing the right technique depends on hemorrhoid grade, presence of external components, surgeon experience, and patient preference.

Hemorrhoidectomy addresses a range of anorectal conditions where haemorrhoidal tissue is the primary pathology:

• Grade III internal hemorrhoids: Prolapse requiring manual reduction, causing bleeding, mucous discharge, and perianal soiling that significantly impacts quality of life.
• Grade IV internal hemorrhoids: Permanently prolapsed, incarcerated, or strangulated hemorrhoids that cannot be reduced and carry a risk of thrombosis and necrosis.
• Large symptomatic external hemorrhoids: Skin-covered vascular and fibrous tissue at the anal verge causing pain, hygiene difficulties, and chronic skin irritation.
• Mixed (internal-external) hemorrhoidal disease: Combined prolapsing internal and external components that cannot be adequately addressed by banding or sclerotherapy alone.
• Acutely thrombosed hemorrhoids: Painful thrombosed external hemorrhoids presenting within 72 hours of onset may benefit from surgical excision rather than conservative management.
• Recurrent hemorrhoids after failed office procedures: Patients who have undergone multiple courses of rubber-band ligation or infrared coagulation with persistent or recurrent symptoms.
• Hemorrhoids in the context of anal fissure or fistula: Concurrent pathology may be addressed at the same operative sitting, subject to surgeon judgment.

Hemorrhoidectomy is not indicated for Grade I or II disease, nor is it first-line therapy for patients with inflammatory bowel disease affecting the anorectum, bleeding diatheses, or significant portal hypertension, where alternatives must be weighed carefully.

Appropriate patient selection is critical to optimising outcomes and minimising morbidity from hemorrhoidectomy.

Candidates typically include:

• Adults with Grade III or IV internal hemorrhoids confirmed on proctoscopy or colonoscopy
• Patients who have failed at least two courses of office-based procedures (rubber-band ligation, sclerotherapy) or conservative therapy
• Patients with large external hemorrhoids or mixed disease causing chronic pain, prolapse, or hygiene problems
• Individuals with acute strangulated or thrombosed hemorrhoids requiring urgent intervention
• Patients medically fit for general, spinal, or regional anaesthesia

Pre-operative evaluation includes:

• Detailed anorectal examination including digital rectal examination, proctoscopy, and anoscopy
• Colonoscopy or flexible sigmoidoscopy to exclude colorectal malignancy in patients with rectal bleeding, particularly those over 40 years
• Full blood count, coagulation screen, and metabolic panel
• Review of anticoagulant and antiplatelet medications — bridging strategies must be discussed with the prescribing physician
• Assessment of anorectal sphincter function in patients with incontinence symptoms, using anorectal manometry if indicated

Relative contraindications include severe portal hypertension, Crohn's disease involving the anorectum, active infection, severe immune suppression, and significant coagulopathy not correctable pre-operatively. Pregnancy is a contraindication to elective surgery; most hemorrhoids in pregnancy are managed post-partum.

Several established surgical techniques exist, each with distinct advantages and evidence profiles:

1. Milligan-Morgan Open Hemorrhoidectomy: The most widely practised technique worldwide. Three primary hemorrhoidal pedicles (left lateral, right anterior, right posterior) are excised with scissors or diathermy, ligating the pedicle at its base. Wounds are left open to heal by secondary intention, reducing the risk of wound infection but prolonging healing to 4–6 weeks. Long-term cure rates exceed 95%.

2. Ferguson Closed Hemorrhoidectomy: The dominant technique in the United States. Identical dissection to Milligan-Morgan, but wounds are closed with continuous absorbable suture. Healing is faster (2–3 weeks), but wound breakdown and infection rates are slightly higher. Outcomes are equivalent to the open method.

3. Stapled Hemorrhoidopexy (Procedure for Prolapse and Hemorrhoids — PPH): A circular stapling device excises a doughnut of rectal mucosa above the hemorrhoidal columns, lifting prolapsed tissue and interrupting arterial supply. Significantly less post-operative pain (operates above the dentate line), shorter hospital stay, and faster return to work. However, recurrence rates at 5 years are higher than excisional hemorrhoidectomy (~10–15% vs <5%), and it does not address external components. Serious rare complications include rectal perforation and rectovaginal fistula.

4. Transanal Hemorrhoidal Dearterialization (THD) / Doppler-guided Hemorrhoid Artery Ligation (DGHAL): A Doppler probe identifies and suture-ligates the terminal branches of the superior hemorrhoidal artery, reducing blood flow to the hemorrhoidal plexus. A mucopexy suture then repositions prolapsing tissue. Minimal post-operative pain, no external wounds. Best suited for Grade II–III hemorrhoids; Grade IV recurrence rates are higher.

5. LigaSure or Harmonic Scalpel Hemorrhoidectomy: Energy-based vessel-sealing devices used in lieu of traditional ligation-and-excision. Reduced operative time and equivalent post-operative pain compared to conventional diathermy techniques.

Hemorrhoidectomy remains the gold-standard surgical treatment for advanced hemorrhoidal disease, offering benefits that outweigh those of non-surgical alternatives in appropriately selected patients:

• High cure rate: Excisional hemorrhoidectomy achieves cure in 93–96% of patients with Grade III–IV disease, with a recurrence rate below 5% at five years — significantly lower than rubber-band ligation (20–30% recurrence) or stapled PPH (10–15%).
• Definitive resolution of prolapse: Surgical excision eliminates prolapsed tissue permanently, resolving mucous discharge, soiling, and the discomfort of manual reduction.
• Cessation of bleeding: Rectal bleeding — the most common presenting complaint — resolves in virtually all patients following surgery.
• Addresses external disease: Unlike PPH or THD, excisional hemorrhoidectomy simultaneously removes external hemorrhoidal skin tags and external components, providing comprehensive anatomical correction.
• Proven long-term durability: Decades of follow-up data confirm sustained symptom relief, with most patients requiring no further anorectal intervention for hemorrhoidal disease.
• Quality of life improvement: Validated anorectal symptom scores (e.g., Cleveland Clinic Hemorrhoid Score) consistently show significant improvements at 6 and 12 months post-operatively.
• Same-day or short-stay surgery: Most hemorrhoidectomies are performed as day-case or 23-hour procedures, minimising health-system burden and allowing early return home.

Hemorrhoidectomy is a safe procedure with a low overall complication rate, but patients must be counselled regarding potential adverse events:

Common (occurring in 5–30% of patients):

• Post-operative pain: The most significant drawback of excisional hemorrhoidectomy. Pain arises from anal sphincter spasm and wound inflammation, typically peaking in the first 48–72 hours. Managed with a multimodal regimen including non-steroidal anti-inflammatory drugs (NSAIDs), opioids, topical anaesthetics, and sitz baths. Stool softeners are essential to reduce pain during early bowel movements.
• Urinary retention: Occurs in 5–15% of patients, related to perioperative fluid management and perianal pain inhibiting voiding. Usually resolves with a brief period of catheterisation.
• Post-operative bleeding: Primary bleeding (within 24 hours) occurs in approximately 1–2% of cases; secondary bleeding (7–14 days post-operatively) is more common and may require examination under anaesthesia.

Less common (1–5%):

• Wound infection or abscess: Risk is higher with closed (Ferguson) technique. Managed with antibiotics or incision and drainage.
• Anal stenosis (stricture): Narrowing of the anal canal from excessive mucosal excision or scarring, managed with graduated anal dilation.
• Anal fissure: May develop at wound edges; most resolve with topical glyceryl trinitrate or calcium channel blockers.

Rare but serious (<1%):

• Faecal incontinence: Especially if internal sphincter injury occurs; thorough pre-operative sphincter assessment is essential.
• Fournier's gangrene: Extremely rare life-threatening necrotising fasciitis of the perineum requiring emergency debridement.
• Rectovaginal fistula: Primarily a risk of the stapled PPH technique.

Structured post-operative care and follow-up are essential to achieving optimal outcomes after hemorrhoidectomy.

Immediate post-operative period (Days 0–7):

• Most patients are discharged on the day of surgery or after one overnight stay. Pain control is the primary concern: a multimodal regimen of paracetamol, NSAIDs (e.g., ibuprofen 400 mg three times daily), and short-course opioids (tramadol or codeine) is standard.
• Sitz baths (warm water soaks of the perineum for 10–15 minutes) two to three times daily reduce sphincter spasm and promote wound cleanliness.
• Dietary fibre supplementation (psyllium husk 10–20 g daily) and adequate hydration (2–3 litres/day) prevent constipation and reduce pain with bowel movements.
• Stool softeners (lactulose, macrogol) are prescribed for the first two weeks.

Recovery timeline:

• Week 1–2: Rest at home; avoid heavy lifting and prolonged sitting. Bleeding and discharge from wounds is normal. Pain with bowel movements is expected.
• Week 2–4: Gradual return to sedentary work; continued fibre supplementation. Wounds heal progressively.
• Week 4–6: Full activity including physical labour and exercise; open wounds (Milligan-Morgan) typically healed by 6 weeks. Closed wounds (Ferguson) heal by 3–4 weeks.

Follow-up appointments: A clinical review at 4–6 weeks confirms wound healing, assesses continence, and addresses residual symptoms. A second review at 3 months evaluates long-term outcomes. Patients with any concern about anal stenosis undergo graduated dilation at follow-up. Annual anorectal review is recommended for high-risk patients.

Long-term lifestyle modifications — high-fibre diet, adequate hydration, regular physical activity, and avoidance of prolonged straining — are essential to prevent recurrence.

The total cost of hemorrhoidectomy varies considerably based on geography, facility type, surgical technique, and the extent of disease. Understanding the components of cost helps patients plan and compare options effectively.

Key cost determinants include:

• Country and healthcare system: Hemorrhoidectomy in the United States costs USD 3,000–8,000 in outpatient settings; hospital admission can push costs to USD 10,000–15,000. In medical tourism destinations, the same procedure is available for USD 800–3,000 in India, Thailand, Mexico, and Turkey, with equivalent outcomes at JCI-accredited centres.
• Surgical technique: Stapled hemorrhoidopexy (PPH) and THD/DGHAL procedures utilise specialised disposable devices (the PPH stapler costs approximately USD 300–500), increasing consumable costs. Conventional excisional hemorrhoidectomy using diathermy is less expensive on a consumables basis.
• Anaesthesia type: Spinal anaesthesia is less costly than general anaesthesia; local anaesthesia with sedation (for selected cases) is least expensive.
• Hospital stay: Day-case surgery significantly reduces facility fees compared to inpatient admission.
• Surgeon experience and accreditation: Colorectal surgeons at tertiary referral centres command higher fees; however, their lower complication and revision rates may offset higher initial costs.
• Pre-operative investigations: Colonoscopy, blood tests, and anaesthetic assessment add to total expenditure.
• Post-operative analgesia and medications: Prescribed drugs, dressings, and nursing support at home carry additional costs.

Patients considering surgery abroad should verify that the quoted package includes surgeon fees, anaesthesia, hospital facility, nursing care, medications, and at least one post-operative review. Travel health insurance covering surgical complications is strongly advised.

Not all hemorrhoidal disease requires surgery. A stepwise approach, escalating from conservative to surgical management based on grade and symptom severity, is recommended by colorectal surgical societies worldwide.

Conservative measures (Grade I–II, and mild Grade III):

• Dietary modification: High-fibre diet (25–35 g/day) and adequate hydration reduce straining and the frequency of symptomatic episodes. Randomised trials show fibre supplementation reduces bleeding risk by approximately 50%.
• Sitz baths and topical agents: Warm water soaks reduce sphincter spasm and provide symptomatic relief; topical anaesthetics (lidocaine), corticosteroids, and astringents (witch hazel) provide short-term comfort but do not treat underlying disease.
• Flavonoids (e.g., micronised purified flavonoid fraction — Daflon): Venotonic agents with moderate evidence for reducing bleeding and prolapse in Grade I–III hemorrhoids, particularly during pregnancy.

Office-based procedures (Grade I–III):

• Rubber-band ligation (RBL): The most effective non-surgical treatment. Elastic bands applied above the dentate line cause ischaemic necrosis and fibrosis of the hemorrhoidal pedicle. Highly effective for Grade II–III internal hemorrhoids; may require multiple sessions. Recurrence rate is 20–30% at 5 years.
• Sclerotherapy: Injection of sclerosant (phenol in oil, polidocanol) causes fibrosis; best for Grade I–II bleeding hemorrhoids. Less effective than RBL for prolapse.
• Infrared coagulation (IRC): Equivalent efficacy to sclerotherapy for Grade I–II; used as an alternative in anticoagulated patients.

Choosing between surgery and alternatives: Hemorrhoidectomy is clearly superior for Grade III–IV disease, failed office-based procedures, and mixed internal-external disease. For Grade II hemorrhoids, a shared decision-making discussion weighing the pain of surgery against the recurrence risk of banding is appropriate.